A study conducted by researchers at Oxford Population Health has found that women who are diagnosed with early-stage breast cancer today are 66 percent less likely to die from the disease within five years of diagnosis than they were 20 years ago. The study, which was funded by Cancer Research ... READ MORE
News Archive
Beacon Therapeutics launched to develop new generation of gene therapies for retinal diseases
A new ophthalmic gene therapy company, which aims to restore and improve the vision of patients with retinal diseases, has been launched. Beacon Therapeutics will develop a new generation of gene therapies to treat a range of rare and more common retinal diseases that result in blindness. The ... READ MORE
Multi-cancer blood test shows real promise in NHS trial
An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms. The test also correctly identified the original site of cancer in 85 percent of those cases. The ... READ MORE
Research profile: the importance of doing research alongside clinical work
Francesca Tabacchi, a specialist oncology dietitian at Oxford University Hospitals, is currently being funded by the NIHR Oxford Biomedical Research Centre to do a PhD on malnutrition and nutritional support in cancer patients undergoing chemotherapy. “I was very excited to start my research ... READ MORE
My journey towards being a citizen scientist – Maria Buckley, Step Change project
The NIHR Oxford Biomedical Research Centre is part of STEP CHANGE, a three-year European Commission project to support five citizen science projects. The study being led by the BRC is looking at the role of steroid hormones in the treatment of non-alcoholic fatty liver disease (NAFLD), obesity and ... READ MORE
New imaging centre performs first stroke thrombectomy
A new imaging centre at the John Radcliffe Hospital carried out its first stroke thrombectomy. The Acute Multidisciplinary and Interventional Centre (AMIIC) carried out the procedure on 17 May as part of its partnership with Oxford University Hospitals (OUH) NHS Foundation Trust. A ... READ MORE
Genetic signals that cause ankylosing spondylitis uncovered
A study by University of Oxford researchers has uncovered the genetic signals that cause ankylosing spondylitis, a common form of spinal arthritis. The results of the study, published in the journal Cell Genomics, offer new hope to patients and their families, as they pave the way for the ... READ MORE
Study shows need for greater screening for frailty in emergency hospital admissions
A new study has shown the need for more widespread screening for frailty in unplanned admissions to hospitals to better inform the care received by patients. Researchers at Oxford University Hospitals (OUH) NHS Foundation Trust, supported by the NIHR Oxford Biomedical Research Centre, carried ... READ MORE
Barbara Casadei wins 2022 Lucian award
The Oxford BRC’s Theme Lead for Cardiovascular Medicine, Professor Barbara Casadei, has been awarded the annual Louis and Artur Lucian Award for outstanding research in the field of circulatory diseases. The award winner receives a prize of 75,000 Canadian dollars and is invited for a formal ... READ MORE
Landmark antibody study to test immune responses against COVID-19
Thousands of immunosuppressed people, including patients at Oxford University Hospitals (OUH), have the chance to take part in a landmark new study investigating which people are still at the greatest risk of COVID-19 infection after vaccination. Researchers hope the STRAVINSKY study’s findings ... READ MORE
New tool uses health records to predict risk of developing lung cancer
Researchers from the Universities of Oxford and Nottingham have developed a new tool that can identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives. The researchers ... READ MORE
‘Game-changing’ drug found to be effective to treat chronic pouchitis
A study led by Oxford researchers has found that the drug vedolizumab can induce remission in patients who have chronic pouchitis after surgery for ulcerative colitis. Twelve percent of people with ulcerative colitis need surgery to have their colon removed. Most have an ileo-anal pouch ... READ MORE
New approach to nail bed injury surgery could cut NHS costs
A new Oxford study, supported by the NIHR Oxford Biomedical Research Centre, shows that changing clinical practice for finger injuries in children could save the NHS £720,000 per year. Nail bed injuries in children are very common. They are generally caused by a child crushing their fingertip in ... READ MORE
Prostate cancer AI diagnosis tool begins evaluation in Oxford
New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust Researchers and clinicians in Oxford have begun an evaluation of artificial intelligence (AI) software that could help ... READ MORE
Professor Barbara Casadei named NIHR Senior Investigator
The Oxford BRC’s Theme Lead for Cardiovascular Medicine, Professor Barbara Casadei, has been named a National Institute of Health and Care Research (NIHR) Senior Investigator, while three other Oxford BRC researchers have been reappointed to this prestigious position in recognition of ... READ MORE
Citizen scientists invited to help tackle antibiotic resistance
A research team in Oxford has launched a new project involving members of the public that is aimed at developing diagnostics for infection and antibiotic resistance. The team of physicists, microbiologists, data scientists and doctors, who are supported by the NIHR Oxford Biomedical Research ... READ MORE
Bioelectronic implant offers intelligent therapy to treat incontinence
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants. Amber Therapeutics, a University of Oxford spin-out company developing intelligent bioelectrical therapies, applied the Picostim-DyNeuMo research ... READ MORE
An open book? New genetic mutation linked to rare conditions
Researchers have discovered that a rare type of genetic variant can be responsible for two well-known skeletal disorders. Whereas many genetic conditions are caused by structural variations that involve deletions, insertions or duplications of segments of DNA, the scientists found that the ... READ MORE
New imaging centre officially opened
A new Acute Multidisciplinary Imaging and Interventional Centre (AMIIC), based at the John Radcliffe Hospital, has been officially opened. AMIIC, part of the University of Oxford’s Radcliffe Department of Medicine, was previously known as AVIC (Acute Vascular Imaging Centre). The newly ... READ MORE
National guidelines produced on use of genomics in treatment of IBD
National guidelines have been developed for clinicians on the use of genomics to diagnose and care for patients with monogenic inflammatory bowel disease (IBD), a group of intestinal disorders caused by variations in a single gene. The new guidelines, unveiled in an article in the Lancet ... READ MORE
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 35
- Next Page »